KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Asset Utilization Ratio (2016 - 2025)

Supernus Pharmaceuticals has reported Asset Utilization Ratio over the past 14 years, most recently at 0.5 for Q4 2025.

  • Quarterly Asset Utilization Ratio rose 2.52% to 0.5 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.5 through Dec 2025, up 2.52% year-over-year, with the annual reading at 0.51 for FY2025, 1.89% up from the prior year.
  • Asset Utilization Ratio was 0.5 for Q4 2025 at Supernus Pharmaceuticals, up from 0.49 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.5 in Q4 2025 and troughed at 0.36 in Q4 2021.
  • The 5-year median for Asset Utilization Ratio is 0.44 (2023), against an average of 0.43.
  • Year-over-year, Asset Utilization Ratio dropped 2.21% in 2022 and then grew 21.75% in 2023.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.36 in 2021, then rose by 9.95% to 0.39 in 2022, then increased by 20.64% to 0.47 in 2023, then grew by 2.99% to 0.49 in 2024, then grew by 2.52% to 0.5 in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Asset Utilization Ratio are 0.5 (Q4 2025), 0.49 (Q3 2025), and 0.49 (Q2 2025).